ROIV
USDRoivant Sciences Ltd. Common Shares
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$19.550
Máximo
$19.890
Mínimo
$19.315
Volume
9.01M
Fundamentos da empresa
Capitalização de mercado
13.6B
Setor
Biotecnologia
País
United Kingdom
Estatísticas de negociação
Volume médio
7.66M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update
BASEL, Switzerland and LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today reported its financial results for the second quarter ended September 30, 2025, and provided a business update.
Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $25
Citigroup analyst Samantha Semenkow maintains Roivant Sciences with a Buy and raises the price target from $16 to $25.
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (NASDAQ:IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m.
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
BASEL, Switzerland and LONDON and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, November 10, 2025, to
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.